Primary Care Clinics in Devils Lake, ND Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Premier Healthcare Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 425 College Dr S, Ste #14, Devils Lake, ND 58301 Phone: 701-662-8662 Fax: 701-662-8217 |
Chi St Alexius Health Devils Lake Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 425 College Dr S Ste 14, Devils Lake, ND 58301 Phone: 701-662-8662 |
The Sunshine Clinic Pllc Family Medicine Medicare: Medicare Enrolled Practice Location: 503 3rd St Ne, Devils Lake, ND 58301 Phone: 701-662-4300 Fax: 701-662-4322 |
Lifewise Associates Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 210 Highway 2 W Ste 10, Devils Lake, ND 58301 Phone: 701-662-1046 Fax: 866-528-9548 |
Kathryn Kram, Chiropractic, Pllc Clinic/Center Medicare: Medicare Enrolled Practice Location: 204 College Dr N, Devils Lake, ND 58301 Phone: 701-662-3443 |
Altru Clinic - Devils Lake Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 1001 7th St Ne, Devils Lake, ND 58301 Phone: 701-662-2157 |
News Archive
Mammogram screening and high fiber diet help combat breast cancer
The key to spotting breast cancer and reducing the risk of fatal disease is early detection and screening. Diagnosing the illness early on helps improve health outcomes. New research shows that participation in mammography screening substantially reduces the rate of advanced and fatal breast cancer.
Catalysis Foundation for Health to discover new TB biomarkers with $5M Bill & Melinda Gates Foundation grant
The Catalysis Foundation for Health (Catalysis), a 501 (c) (3) non-profit entity dedicated to developing sustainable diagnostics for the developing world, announced today that it has received a $5 million grant from the Bill & Melinda Gates Foundation. The grant money will be used to discover new tuberculosis (TB) biomarkers that can be used to improve diagnostic tests and potentially develop more effective TB treatments.
SARS-CoV-2 invasion of central nervous system through olfactory tract
As the COVID-19 pandemic continues to claim lives throughout the world, the evidence is mounting that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract as well as the central nervous system. Now, a new study by German researchers published on the preprint server bioRxiv in June 2020 describes various neurological manifestations of COVID-19, as well as the underlying pathophysiology.
VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new ReninSense680(TM) FAST imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo.
Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study
Optimer Pharmaceuticals, Inc. today announced the presentation of new data from fidaxomicin's North American phase 3 study at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia, PA.
› Verified 2 days ago